| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |